![glp-1 agonist mechanism of action of [25] GLP-1 and Anesthesia: Considerations and](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
glp-1 agonist mechanism of action of [25] GLP-1 and Anesthesia: Considerations and
Description
CKD: chronic kidney disease
![glp-1 agonist mechanism of action of [25] GLP-1 and Anesthesia: Considerations and](https://www.apexanesthesia.com/wp-content/uploads/2024/05/article_GLP1_organ_effects.jpg)
Available from: [Google Scholar] 50.Finan B, Ma T, Ottaway N, Muller TD, Habegger KM, Heppner KM, et al
![glp-1 agonist mechanism of action of [25] GLP-1 and Anesthesia: Considerations and](https://res.cloudinary.com/broadcastmed/image/fetch/q_auto,f_auto,dpr_auto/https://www.glaucomaphysician.net/media/30hgcds4/pg15_fig1_sept25.jpg)
At 2.5 mg/mL, that is 10 units
![glp-1 agonist mechanism of action of [25] GLP-1 and Anesthesia: Considerations and](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig2_HTML.png)
Food and Drug Administration (FDA) for safety, effectiveness, or quality
![glp-1 agonist mechanism of action of [25] GLP-1 and Anesthesia: Considerations and](https://medrac.web.unc.edu/wp-content/uploads/sites/22579/2025/03/image-6.png)
